Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Philippe Colson and Didier Raoult.
Connection Strength

18.847
  1. A Possible Role of Remdesivir and Plasma Therapy in the Selective Sweep and Emergence of New SARS-CoV-2 Variants. J Clin Med. 2021 Jul 24; 10(15).
    View in: PubMed
    Score: 0.958
  2. Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage. Clin Microbiol Infect. 2021 Sep; 27(9):1352.e1-1352.e5.
    View in: PubMed
    Score: 0.945
  3. Global Discrepancies between Numbers of Available SARS-CoV-2 Genomes and Human Development Indexes at Country Scales. Viruses. 2021 04 28; 13(5).
    View in: PubMed
    Score: 0.942
  4. Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa: An investigational study. Travel Med Infect Dis. 2021 Mar-Apr; 40:101980.
    View in: PubMed
    Score: 0.927
  5. Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19. Int J Antimicrob Agents. 2021 Jan; 57(1):106238.
    View in: PubMed
    Score: 0.922
  6. Evidence of SARS-CoV-2 re-infection with a different genotype. J Infect. 2021 04; 82(4):84-123.
    View in: PubMed
    Score: 0.913
  7. Temporal and age distributions of SARS-CoV-2 and other coronaviruses, southeastern France. Int J Infect Dis. 2020 Dec; 101:121-125.
    View in: PubMed
    Score: 0.904
  8. Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults. Eur J Clin Microbiol Infect Dis. 2020 Oct; 39(10):1983-1987.
    View in: PubMed
    Score: 0.900
  9. Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2020 Aug; 39(8):1601-1603.
    View in: PubMed
    Score: 0.876
  10. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020 04; 55(4):105932.
    View in: PubMed
    Score: 0.870
  11. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents. 2020 03; 55(3):105923.
    View in: PubMed
    Score: 0.867
  12. Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2. Euro Surveill. 2020 02; 25(8).
    View in: PubMed
    Score: 0.865
  13. Ancestrality and Mosaicism of Giant Viruses Supporting the Definition of the Fourth TRUC of Microbes. Front Microbiol. 2018; 9:2668.
    View in: PubMed
    Score: 0.797
  14. Giant Viruses of Amoebae: A Journey Through Innovative Research and Paradigm Changes. Annu Rev Virol. 2017 09 29; 4(1):61-85.
    View in: PubMed
    Score: 0.727
  15. Evaluation of Strategies to Fight COVID-19: The French Paradigm. J Clin Med. 2021 Jun 30; 10(13).
    View in: PubMed
    Score: 0.238
  16. SARS-CoV-2 variant from India to Marseille: The still active role of ports in the introduction of epidemics. Travel Med Infect Dis. 2021 Jul-Aug; 42:102085.
    View in: PubMed
    Score: 0.237
  17. Implementation of an in-house real-time reverse transcription-PCR assay to detect the emerging SARS-CoV-2 N501Y variants. J Clin Virol. 2021 07; 140:104868.
    View in: PubMed
    Score: 0.236
  18. SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment. Viruses. 2021 05 12; 13(5).
    View in: PubMed
    Score: 0.236
  19. Mink, SARS-CoV-2, and the Human-Animal Interface. Front Microbiol. 2021; 12:663815.
    View in: PubMed
    Score: 0.234
  20. Implementation of an in-house real-time reverse transcription-PCR assay for the rapid detection of the SARS-CoV-2 Marseille-4 variant. J Clin Virol. 2021 06; 139:104814.
    View in: PubMed
    Score: 0.234
  21. Emergence and outcomes of the SARS-CoV-2 'Marseille-4' variant. Int J Infect Dis. 2021 May; 106:228-236.
    View in: PubMed
    Score: 0.234
  22. COVID-19 re-infection. Eur J Clin Invest. 2021 May; 51(5):e13537.
    View in: PubMed
    Score: 0.234
  23. Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann. Int J Antimicrob Agents. 2021 Mar; 57(3):106306.
    View in: PubMed
    Score: 0.232
  24. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited. Int J Antimicrob Agents. 2021 Jan; 57(1):106243.
    View in: PubMed
    Score: 0.230
  25. Natural history of COVID-19 and therapeutic options. Expert Rev Clin Immunol. 2020 12; 16(12):1159-1184.
    View in: PubMed
    Score: 0.230
  26. Coinfections with SARS-CoV-2 and other respiratory viruses in Southeastern France: A matter of sampling time. J Med Virol. 2021 04; 93(4):1878-1881.
    View in: PubMed
    Score: 0.230
  27. Different pattern of the second outbreak of COVID-19 in Marseille, France. Int J Infect Dis. 2021 Jan; 102:17-19.
    View in: PubMed
    Score: 0.227
  28. Does spitting in public play a role in transmitting SARS-CoV-2? Travel Med Infect Dis. 2020 Jul - Aug; 36:101759.
    View in: PubMed
    Score: 0.221
  29. Comparison of mortality associated with respiratory viral infections between December 2019 and March 2020 with that of the previous year in Southeastern France. Int J Infect Dis. 2020 Jul; 96:154-156.
    View in: PubMed
    Score: 0.220
  30. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738.
    View in: PubMed
    Score: 0.220
  31. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis. 2020 Jun; 39(6):1059-1061.
    View in: PubMed
    Score: 0.220
  32. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. Microb Pathog. 2020 Aug; 145:104228.
    View in: PubMed
    Score: 0.220
  33. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663.
    View in: PubMed
    Score: 0.219
  34. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul; 56(1):105949.
    View in: PubMed
    Score: 0.218
  35. SARS-CoV-2: fear versus data. Int J Antimicrob Agents. 2020 May; 55(5):105947.
    View in: PubMed
    Score: 0.218
  36. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 May; 55(5):105938.
    View in: PubMed
    Score: 0.218
  37. A Phylogenomic Study of Acanthamoeba polyphaga Draft Genome Sequences Suggests Genetic Exchanges With Giant Viruses. Front Microbiol. 2018; 9:2098.
    View in: PubMed
    Score: 0.196
  38. A Large Open Pangenome and a Small Core Genome for Giant Pandoraviruses. Front Microbiol. 2018; 9:1486.
    View in: PubMed
    Score: 0.194
  39. Evaluation of self-collected rectal swabs for the detection of bacteria responsible for sexually transmitted infections in a cohort of HIV-1-infected patients. J Med Microbiol. 2017 Jun; 66(6):693-697.
    View in: PubMed
    Score: 0.180
  40. Consequences of the COVID-19 Outbreak Lockdown on Non-Viral Infectious Agents as Reported by a Laboratory-Based Surveillance System at the IHU Méditerranée Infection, Marseille, France. J Clin Med. 2021 Jul 21; 10(15).
    View in: PubMed
    Score: 0.060
  41. SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence. J Clin Med. 2021 Jun 15; 10(12).
    View in: PubMed
    Score: 0.059
  42. Correlation Between 3790 Quantitative Polymerase Chain Reaction-Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates. Clin Infect Dis. 2021 06 01; 72(11):e921.
    View in: PubMed
    Score: 0.059
  43. Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France. Clin Microbiol Infect. 2021 Oct; 27(10):1516.e1-1516.e6.
    View in: PubMed
    Score: 0.059
  44. Automated Western immunoblotting detection of anti-SARS-CoV-2 serum antibodies. Eur J Clin Microbiol Infect Dis. 2021 Jun; 40(6):1309-1317.
    View in: PubMed
    Score: 0.058
  45. Evaluation of the Panbio COVID-19 Rapid Antigen Detection Test Device for the Screening of Patients with COVID-19. J Clin Microbiol. 2021 01 21; 59(2).
    View in: PubMed
    Score: 0.058
  46. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791.
    View in: PubMed
    Score: 0.056
  47. Child with liver transplant recovers from COVID-19 infection. A case report. Arch Pediatr. 2020 Jul; 27(5):275-276.
    View in: PubMed
    Score: 0.055
  48. Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot. Travel Med Infect Dis. 2020 Jul - Aug; 36:101632.
    View in: PubMed
    Score: 0.055
  49. Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? Travel Med Infect Dis. 2020 Mar - Apr; 34:101624.
    View in: PubMed
    Score: 0.054
  50. Teicoplanin: an alternative drug for the treatment of COVID-19? Int J Antimicrob Agents. 2020 Apr; 55(4):105944.
    View in: PubMed
    Score: 0.054
  51. Experimental Inoculation in Rats and Mice by the Giant Marseillevirus Leads to Long-Term Detection of Virus. Front Microbiol. 2018; 9:463.
    View in: PubMed
    Score: 0.047
  52. Tailed giant Tupanvirus possesses the most complete translational apparatus of the known virosphere. Nat Commun. 2018 02 27; 9(1):749.
    View in: PubMed
    Score: 0.047
  53. Pacmanvirus, a New Giant Icosahedral Virus at the Crossroads between Asfarviridae and Faustoviruses. J Virol. 2017 07 15; 91(14).
    View in: PubMed
    Score: 0.045
  54. MimiLook: A Phylogenetic Workflow for Detection of Gene Acquisition in Major Orthologous Groups of Megavirales. Viruses. 2017 04 07; 9(4).
    View in: PubMed
    Score: 0.044
  55. Implementation and Initial Analysis of a Laboratory-Based Weekly Biosurveillance System, Provence-Alpes-Côte d'Azur, France. Emerg Infect Dis. 2017 04; 23(4):582-589.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.